Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

SpinalCyte, LLC

  • Pete OHeeron, SpinalCyte, LLC

Based in Houston, Texas, SpinalCyte, LLC is a regenerative medicine company developing an innovative solution for spinal disc replacement using human dermal fibroblasts. Currently, SpinalCyte holds 36 U.S. and international issued patents and has filed for an additional 40 patents pending. SpinalCyte holds 117 U.S. and International Patents pending and issued across a variety of clinical pathways, including disc degeneration, cancer, diabetes, liver failure and heart failure. Funded entirely by angel investors, SpinalCyte represents the next generation of medical advancement in cell therapy.

  • Date:Tuesday, February 12
  • Time:1:15 PM - 1:30 PM
  • Room:Gramercy
  • Location:7th Floor
  • Session Type:Company Presentation
  • Company Presentation - Presentation Type:Privately Funded Company
  • Submission ID:23512
  • Goal for Presentation:To raise awareness of fibroblasts as an alternative cell source to stem cells.
  • Company Website:www.spinalcyte.com
  • Company HQ City:Houston
  • Company HQ State:Texas
  • Company HQ Country:United States
  • Total Amount Raised to Date, in All Rounds:$17M
  • Year Founded:2009
  • Main Therapeutic Focus:Regenerative Medicine
  • Lead Product in Development:CybroCell
  • Development Phase of Primary Product:Phase II
Speakers
Pete OHeeron
SpinalCyte, LLC
Back